Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasuharu Yamaguchi is active.

Publication


Featured researches published by Yasuharu Yamaguchi.


Alimentary Pharmacology & Therapeutics | 2005

A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection‐induced ulceration

Yasuharu Yamaguchi; Naoya Katsumi; Masaru Tauchi; Masao Toki; Kenji Nakamura; Kei Aoki; Yasushi Morita; Miki Miura; Katsuro Morozumi; Hitoshi Ishida; Shin'ichi Takahashi

Background : It has been reported that inhibitors of gastric acid secretion prevent bleeding after endoscopic mucosal resection for mucosal gastric neoplasm. However, uncertain whether an histamine2‐receptor antagonist or proton‐pump inhibitor is more effective.


Digestion | 2016

Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels - The ABC Method

Yasuharu Yamaguchi; Yasuhiko Nagata; Ryuuta Hiratsuka; Yoshihiko Kawase; Tatsurou Tominaga; Shunji Takeuchi; Shinya Sakagami; Shusei Ishida

Background:Helicobacter pylori (Hp) infection and gastric atrophy are both risk factors for gastric cancer. Recently it has been found that X-ray examination for gastric cancer screening does not have much effect on the detection rate for gastric cancer in Japan. A candidate for a new mass screening for gastric cancer, the ABC method, using the combination assay of Hp and serum pepsinogen, was useful for identifying the development of gastric cancer in high-risk and low-risk populations. People with higher cancer risk are recommended to receive endoscopy. The ABC method was carried out as a gastric cancer mass-screening on the initiative of Nishitokyo Medical Association in Nishitokyo city from 2011. This paper reviewed the present status of gastric cancer screening using the ABC method, including the latest results of our ongoing screening. Summary: We report results for 36,627 individuals from 2011 to 2013. Among them, 16,965 received blood examination for the ABC method. Of those, 8,083 planned to undergo endoscopic examination according to stratification of the risk for the development of gastric cancer. In fact, a total of 2,911 individuals underwent endoscopic examination. Gastric cancer was detected in 65 patients, including 52 (80%) diagnosed with early gastric cancer. The ABC method was not organized screening but opportunistic screening. X-ray examination was the organized screening that was ongoing during the same period. Detection cost for 1 gastric cancer case using the ABC method was cheaper than the conventional X-ray screening method (¥1,267,452 vs. ¥2,807,763). Key Messages: Although further large epidemiological studies are required, the ABC method might be positioned as an effective mass screening for gastric cancer.


Journal of Clinical Gastroenterology | 2007

Resection area of 15 mm as dividing line for choosing strip biopsy or endoscopic submucosal dissection for mucosal gastric neoplasm.

Yasuharu Yamaguchi; Naoya Katusmi; Kei Aoki; Masao Toki; Kenji Nakamura; Nobutsugu Abe; Katsuro Morozumi; Masanori Sugiyama; Hitoshi Ishida; Shin'ichi Takahashi

Background Endoscopic mucosal resection (EMR) is effective treatment for mucosal gastric neoplasm. Endoscopic submucosal dissection (ESD), a novel EMR method, has been reported to enable en bloc resection more frequently than conventional EMR methods such as strip biopsy (SB). However, ESD requires more time than SB. A small lesion can be resected en bloc and effectively treated with SB. Goal To evaluate using a 15 mm resection area as the dividing line between SB and ESD prospectively. Study SB was applied for resection area less than 15 mm (SB group) and ESD for 15 mm or larger resection (ESD group). We compared characteristics of lesions and outcomes of EMR between the 2 groups. Results Ninety lesions were prospectively assigned to SB group (36 lesions) and ESD group (54 lesions). The average neoplasm size was 9.0±3.9 mm in the SB group and 19.1±11.3 mm in the ESD group (P<0.01). The average resection time was 11.7±5.8 minutes in the SB group and 128.9±102.8 minutes in the ESD group (P<0.01). The complete resection rate was 91.6% in the SB group and 83.3% in the ESD group (P=0.25). The complication rate was not significantly different between SB group and ESD group (11.1% vs. 16.7%, P=0.12). During follow-up (median 23±5 mo), 1 patient in each group, who had piecemeal resection at original EMR had recurrent neoplasm. Conclusions Gastric mucosal neoplasms which require only small (<15 mm) resection can be treated with SB, as effectively as with ESD.


Gastrointestinal Endoscopy | 2005

A case of mucin hypersecreting intraductal papillary carcinomas occurring simultaneously in liver and pancreas

Yasuharu Yamaguchi; Nobutsugu Abe; Kyoto Imase; Hideaki Mizuno; Katsuya Chinen; Hideaki Mori; Masanori Sugiyama; Yutaka Atomi; Hitoshi Ishida; Shin'ichi Takahashi

Intraductal papillary mucinous tumor of the pancreas (IPMT) is accepted as a distinct disease entity. Its unique features are attributable primarily to excessive amounts of mucin secreted by the tumor. In contrast, a mucin hypersecreting bile-duct tumor is rare. A subgroup of bile-duct tumors, which clinically and histopathologically resemble IPMT, has been described. This type of tumor excretes excessive mucin that fills the biliary tree and results in segmental dilatation of the intrahepatic bile ducts. Histopathologically, the tumor frequently exhibits intraductal spreading and/or intraductal papillary projections ofmucinproducing columnar epithelium with variable cellular atypia. Based on these characteristic homologies with IPMT, it has been proposed that such papillary mucinous tumors of the intrahepatic bile duct be called intraductal papillary neoplasmof the liver (IPNL). Because thepancreas and the bile duct develop embryonically from the same primordium, such tumors can occur in either of these tissues. However, the simultaneous occurrence of IPNL and IPMT is extremely rare. To our knowledge, only two cases of IPNL associated with IPMTare reported. In neither case was the liver or the pancreatic tumor malignant. Herein, a case is presented of concurrent IPMTand IPNL, both were malignant.


Journal of Gastroenterology and Hepatology | 2003

Endoscopic hemostasis: Safe treatment for peptic ulcer patients aged 80 years or older?

Yasuharu Yamaguchi; Taro Yamato; Naoya Katsumi; Katsuro Morozumi; Takashi Abe; Hitoshi Ishida; Shin Takahashi

Background and Aim: Recently, the number of peptic ulcer patients aged 80 years or older has been increasing. However, little information is available concerning therapeutic endoscopy for these patients. The objective of this study was to evaluate the efficacy of endoscopic hemostasis for peptic ulcer bleeding in patients aged 80 years or older.


United European gastroenterology journal | 2013

Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): A multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial.

Hidekazu Suzuki; Hiroaki Kusunoki; Takeshi Kamiya; Seiji Futagami; Yasuharu Yamaguchi; Toshihiro Nishizawa; Eisuke Iwasaki; Juntaro Matsuzaki; Shin'ichi Takahashi; Choitsu Sakamoto; Ken Haruma; Takashi Joh; Keiko Asakura; Toshifumi Hibi

Background: Since the publication of the Rome III criteria for functional dyspepsia (FD), the evidence about the efficacy of half-dose of proton pump inhibitors for dyspepsia symptoms have been limited. Objective: To examine the efficacy of lansoprazole for functional dyspepsia (FD) diagnosed with the Rome III criteria by the multicentre, double-blind, randomized, placebo-controlled study in Japan. Methods: A total of 54 FD participants were randomized to lansoprazole 15 mg once daily or placebo for a 4-week double-blind treatment period. The primary efficacy endpoint was an overall dyspeptic symptom relief rate evaluated by 5-point Likert scale scores. The alteration of dyspeptic symptom scores during the study period was also assessed. Results: At week 4, the overall dyspeptic symptom relief rates were higher in the lansoprazole group (30.4%) than in the placebo group (6.7%) (p = 0.045). The scores for epigastric pain (p = 0.045) and epigastric burning (p = 0.03) were significantly improved in the lansoprazole group compared to the placebo group, whereas the improvement of the scores for postprandial fullness (p = 0.81) and early satiation (p = 0.33) was not different between lansoprazole and placebo groups. Conclusions: Lansoprazole 15 mg ameliorates dyspeptic symptoms, particularly the epigastric pain syndrome-related symptoms of FD.


Abdominal Imaging | 2003

Annular pancreas complicated by carcinoma of the bile duct: diagnosis by MR cholangiopancreatography and endoscopic ultrasonography.

Yasuharu Yamaguchi; Masanori Sugiyama; Yoshihisa Sato; Y. Mine; Taro Yamato; Hitoshi Ishida; Shin'ichi Takahashi

AbstractIt has been reported that annular pancreas should be evaluated for coexisting malignant tumors. However, no cases have been reported in which magnetic resonance cholangiopancreatography and endoscopic ultrasonography clearly demonstrated an annular pancreas complicated by bile duct carcinoma. We present a case that emphasizes the importance of magnetic resonance cholangiopancreatography and endoscopic ultrasonography in directly confirming a diagnosis of annular pancreas complicated by bile duct carcinoma.


Gastrointestinal Endoscopy | 2000

7142 Endoscopic hemoclipping for upper gastrointestinal bleeding due to mallory-weiss syndrome.

Yasuharu Yamaguchi; Taro Yamato; Yasushi Morita; Miki Miura; Naoya Katsumi; Motoo Kimura; Toshiyuki Hashimoto; Katsuro Morozumi; Yoshikazu Yamaguchi; Takashi Abe; Hitoshi Ishida; Shin'ichi Takahashi

Aim: Endoscopic treatment with sclerotherapy or thermal methods has been widely used for upper gastrointestinal (UGI ) bleeding due to Mallory-Weiss syndrome (MWS). However, the potential drawback of thermal methods and the injection of sclerosing agents is that these may cause excessive tissue injury leading to necrosis and perforation. Recently, endoscopic hemoclipping was shown to be highly effective for as a hemostatic treatment for UGI bleeding. Hemoclipping causes less damage to the surrounding area than sclerotherapy or thermal methods. However, the efficacy and safety of hemoclipping for MWS bleeding has not been reported. The aim of the present study was to assess prospectively the usefulness of endoscopic hemoclipping for MWS bleeding. Methods: This prospective study was performed over a 5 year period beginning in January 1994. When patients were diagnosed with MWS by endoscopy , hemoclipping was performed for patients with active bleeding , visible vessel and/or red clots (Group H). The remaining patients with old clots and linear tears in the Esophagogastric junctional (EGJ) mucosa as the only possible origin of bleeding were conservatively treated (Group C). The clinical data and outcome of endoscopic treatment were compared between these two groups. Results: A total of 58 patients underwent emergency endoscopy for UGI bleeding due to MWS from January 1994 to August 1999. During endoscopic examination, active bleeding was found in 17 patients (29%), a visible vessel in one patient (2%) and red clots in 8 patients (14%); Hemoclipping was performed on all 26 patients. Of the remaining 32 patients, 12 patients (21%) had old clots, and 20 (34%) had linear tears without stigmata of recent hemorrhage in the EGJ; these patients did not receive hemoclipping. Significantly more patients in Group H had shock and trasfusional requirements over 800ml than in Group C [the former 4 (17%) vs 0, the latter 4 (17%) vs 0]. The mean hemoglobin level on admission was significantly lower in Group H (10.6±2.9g/dl)than in Group C (12.2±3.0g/dl). Significantly more patients in Group H had critical concomitant diseases than in Group C [14 (54%) vs 8 (25%)]. However, all patients in Group H successfully underwent endoscopic hemostasis with no rebleeding. No patients in Conservative group had rebleeding. No complications related to the endoscopic procedures and no hospital deaths were found in either group. Conclusion : Endoscopic hemoclipping provided an effective and safe modality for securing hemostasis for MWS bleeding.


Gastrointestinal Endoscopy | 2012

Gastric mucosal longitudinal tears after drowning

Tomohiko Hasue; Yasuharu Yamaguchi; Kenji Nakamura; Masao Toki; Masanori Sugiyama; Shin'ichi Takahashi

A 90-year-old man with spondylosis deformans but no other pertinent medical history was found drowning in a public bath. He was successfully resuscitated by mouthto-mouth respiration without cardiac massage; regurgitation of gastric contents was noted during resuscitation. Three hours after admission to the hospital he had tarry stools and a decrease in hematocrit from 31.1% to 21.5%. EGD revealed several longitudinal mucosal tears with visible vessels in the upper body of the stomach and a massive blood clot in the stomach (A; arrowhead indicates visible vessel). Hemostasis was achieved by endoscopic clipping (B; arrow indicates clip). He had no further bleeding and was discharged in stable condition. DISCLOSURE All authors disclosed no financial relationships relevant to this publication.


Abdominal Imaging | 2002

Anomalous pancreaticobiliary junction demonstrated by extraductal ultrasonography using transduodenoscopic miniprobe

Masanori Sugiyama; Nobutsugu Abe; Yumi Izumisato; G.-Q. Zhang; Yasuharu Yamaguchi; Taro Yamato; Tadahiko Masaki; Toshiyuki Mori; Yutaka Atomi

We present a case of an anomalous pancreaticobiliary junction (a long common channel) that was clearly demonstrated by extraductal ultrasonography with a transduodenoscopic miniprobe placed in the duodenal lumen. The present case suggests a potential indication for the ultrasound miniprobe, in extraductal ultrasonography, in the pancreatobiliary region. In this method, the position of a miniprobe can readily be adjusted under endoscopic guidance, unlike ordinary endoscopic ultrasonography.

Collaboration


Dive into the Yasuharu Yamaguchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge